Jianda Hu Selected Research

Jianda Hu Research Topics

Disease

21	Neoplasms (Cancer) 04/2024 - 06/2013
16	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 11/2014
11	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 10/2017
10	Leukemia 01/2024 - 08/2011
10	Multiple Myeloma 01/2024 - 01/2017
10	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 11/2014
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2024 - 06/2013
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2023 - 06/2013
8	Neutropenia 01/2022 - 10/2012
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2018
6	Mycoses (Diseases, Fungus) 08/2021 - 02/2012
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2023 - 01/2020
5	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2023 - 01/2021
5	Invasive Fungal Infections 07/2021 - 02/2012
4	Lymphoma (Lymphomas) 01/2024 - 01/2020
4	Infections 07/2023 - 11/2017
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 01/2020
3	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 01/2019
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 01/2021
3	Hemorrhage 01/2022 - 01/2020
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 02/2015
3	Sepsis (Septicemia) 01/2021 - 05/2019
3	Burkitt Lymphoma (Burkitt's Lymphoma) 12/2019 - 10/2002
2	Febrile Neutropenia 01/2024 - 10/2019
2	Hyperuricemia 01/2024 - 09/2020
2	Carcinogenesis 01/2024 - 01/2018
2	Disease Progression 01/2023 - 01/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 12/2019
2	Primary Myelofibrosis (Myelosclerosis) 12/2022 - 11/2021
2	Hemophilia A (Haemophilia) 01/2022 - 12/2016
2	Urinary Tract Infections (Urinary Tract Infection) 01/2022 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2022
2	Hematologic Diseases (Blood Diseases) 08/2021 - 06/2019
2	Hypertension (High Blood Pressure) 03/2021 - 01/2020
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 10/2017
2	Diarrhea 01/2020 - 01/2018
2	T-Cell Lymphoma (Lymphoma, T Cell) 10/2017 - 01/2015
1	Pneumonia (Pneumonitis) 01/2024
1	Renal Insufficiency (Renal Failure) 01/2024
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2024

Drug/Important Bio-Agent (IBA)

8	zanubrutinibIBA 09/2023 - 01/2020
7	Imatinib Mesylate (Gleevec)FDA Link 02/2024 - 02/2015
7	Rituximab (Mabthera)FDA Link 01/2024 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2011
5	Bortezomib (Velcade)FDA Link 01/2024 - 01/2018
5	Emodin (Archin)IBA 11/2023 - 11/2014
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 01/2021
5	Inosine Triphosphate (ITP)IBA 07/2023 - 01/2021
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 08/2011
4	Chimeric Antigen ReceptorsIBA 01/2023 - 07/2022
4	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2020
4	NucleophosminIBA 01/2021 - 08/2011
4	Messenger RNA (mRNA)IBA 12/2019 - 10/2002
3	nilotinib FDA Link 02/2024 - 04/2015
3	Dasatinib (BMS 354825)FDA Link 02/2024 - 09/2015
3	Proteasome InhibitorsIBA 01/2024 - 01/2017
3	orelabrutinibIBA 11/2023 - 01/2023
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 12/2002
3	Tyrosine Kinase InhibitorsIBA 06/2019 - 04/2015
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2019 - 01/2016
3	baicalinIBA 01/2018 - 05/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2024 - 01/2017
2	Biosimilar PharmaceuticalsIBA 01/2024 - 01/2020
2	BilirubinIBA 01/2024 - 01/2024
2	Etoposide (VP 16)FDA LinkGeneric 01/2024 - 05/2023
2	NucleolinIBA 12/2023 - 12/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2023 - 08/2021
2	daratumumabIBA 01/2023 - 01/2021
2	axicabtagene ciloleucelIBA 01/2023 - 07/2022
2	Immunoglobulin G (IgG)IBA 01/2022 - 10/2020
2	Factor VIII (Coagulation Factor VIII)IBA 01/2022 - 12/2016
2	camrelizumabIBA 01/2022 - 12/2019
2	hetrombopagIBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 10/2020
2	posaconazole FDA Link 07/2021 - 02/2012
2	carfilzomibIBA 03/2021 - 01/2017
2	ibrutinibIBA 02/2021 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2017
2	Hemoglobins (Hemoglobin)IBA 10/2020 - 09/2020
2	ProcalcitoninIBA 10/2020 - 10/2019
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2017
2	Drug CombinationsIBA 01/2019 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2018
2	baicaleinIBA 01/2018 - 11/2014
2	Micafungin (FK463)FDA Link 01/2018 - 10/2012
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 01/2015
1	flumatinibIBA 02/2024
1	Amylases FDA Link 01/2024
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024
1	Syk KinaseIBA 01/2024
1	XenobioticsIBA 01/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2024

Therapy/Procedure

27	Therapeutics 04/2024 - 02/2012
17	Drug Therapy (Chemotherapy) 01/2024 - 02/2015
8	Hematopoietic Stem Cell Transplantation 01/2024 - 01/2015
3	Immunotherapy 01/2023 - 07/2022
3	Transplantation 08/2021 - 01/2015
2	Salvage Therapy 07/2021 - 02/2012
2	Central Venous Catheters 06/2019 - 08/2017
2	Induction Chemotherapy 06/2019 - 02/2015